✦ LIBER ✦

406 POSTER IMC-18F1, a recombinant human monoclonal antibody (MAb) against the vascular endothelial growth factor receptor-1 (VEGFR-1), in the treatment of patients (pts) with advanced solid malignancies: A Phase 1 study

✍ Scribed by S. Krishnamurthi; P.H.B. Goncalves; F. Fox; N. Hall; E. Rowinsky; J. Schwartz; H. Youssoufian; P. LoRusso

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Icrucumab, a fully human monoclonal anti

✍ Patricia M. LoRusso, Smitha Krishnamurthi, Hagop Youssoufian, Nancy Hall, Floyd 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 176 KB

647 POSTER A phase I dose-escalation stu

✍ R. Cohen; D. Camidge; S. Diab; L. Gore; L. Chow; C. O'Bryant; E. Temmer; F. Fox; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB

648 POSTER A phase I dose-escalation stu

✍ C. Higano; M. Gordon; P. LoRusso; F. Fox; T. Katz; J. Roecker; E. Rowinsky; H. Y 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB

554 POSTER Pharmacokinetic (PK) and phar

✍ M.L. Rothenberg; E. Poplin; P. LoRusso; E. Yu; J. Schwartz; F. Fox; J. Mehnert; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Phase 1 study of ganitumab (AMG 479), a

✍ Haruyasu Murakami, Toshihiko Doi, Nobuyuki Yamamoto… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 228 KB

196 POSTER A phase I trial incorporating

✍ P.C. Fong; R.L. Molife; J. Spicer; T.A. Yap; S. Settatree; L. Digue; G. Attard; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 71 KB